Edoxaban

• MidregiOnal proatrial natriuretic peptide to guide SEcondary Stroke prevention: The MOSES-study Pending
  2024-517600-11-01 Phase III 2 countries Universitaetsspital Basel
• EdoxabaN foR IntraCranial Hemorrhage survivors with Atrial Fibrillation Pending
  2024-518508-31-00 Phase IV 10 countries Hamilton Health Sciences Corporation; PHRI Population Health Research Institute …
• Anticoagulant medicines for Balloon Pulmonary Angioplasty Pending
  2024-518803-23-00 Phase IV 1 country St. Antonius Ziekenhuis
• Short-Term Anticoagulation versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure. The ANDES s… Pending
  2025-520954-12-00 Phase IV 1 country Centre Hospitalier Universite De Laval
• EXPOSURE Study Recruiting
  2024-513353-73-00 Phase II 1 country Medical University Of Vienna
• Thrombolysis in Factor Xa-inhibitors Trial (SIFT) Recruiting
  2023-509907-34-01 Phase III 3 countries Oslo University Hospital HF
• Treatment with a single drug that prevents blood clot formation followed by an anticoagulant drug in patients with irregular heartbeat who h… Recruiting
  2023-509717-36-00 Phase III 7 countries Insel Gruppe AG
• Continuing Anticoagulants and Antiplatelets in Cold snare Polypectomy. Recruiting
  2024-511265-11-01 Phase IV 1 country Fundacion Instituto De Investigacion Sanitaria Aragon
• The Direct Oral Anticoagulation versus Vitamin K Antagonist after Cardiac Surgery (DANCE) Trial Recruiting
  2023-504504-28-00 Phase III 1 country Hamilton Health Sciences Corporation
• Short-term interruption versus continuous anticoagulation in colorectal polypectomy. A randomized multicenter investigator-initiated non-inf… Recruiting
  2024-512194-27-01 Phase IV 1 country Hospital Universitario Ramon Y Cajal
• Can patients with atrial fibrillation discontinue anticoagulant therapy after cardiac surgery: The ATLAAC trial Recruiting
  2022-502986-92-00 Phase IV 2 countries Odense University Hospital
• Anticoagulation for Stroke Prevention In patients with Recent Episodes of Atrial Fibrillation occurring transiently with stress Recruiting
  2023-509142-35-00 Phase IV 10 countries Hamilton Health Sciences Corporation
• Preventing formation of blood clots due to atrial fibrillation, a cardiac arrhythmia that first occurred after coronary bypass surgery, with… Recruiting
  2024-515924-35-00 Phase IV 1 country Icahn School Of Medicine At Mount Sinai
• WOEST-3 Recruiting
  2022-502140-13-00 Phase IV 4 countries St Antonius Hospital
• DANNOAC- The Danish Non-vitamin K Antagonist Oral Anticoagulation Study Ended
  2022-501912-32-00 Phase IV 1 country Bispebjerg Hospital; Gentofte Hospital
• Blood thinners after transcatheter implantation of a new heart valve in patients with aortic stenosis Ended
  2023-510211-20-00 Phase III 1 country Oslo University Hospital HF
• The Nordic Aortic Valve Intervention Trial 4 (NOTION-4) Ended
  2024-518547-38-00 Phase IV 1 country Rigshospitalet
• Determining the clinical relevance of the interaction between enzalutamide and the opioid morphine and the DOAC edoxaban to improve rational… Ended
  2024-517646-34-00 Phase IV 1 country Radboud universitair medisch centrum Stichting
• A trial to learn if andexanet alfa is safe and works to limit bleeding in people who take factor 10a inhibitors and urgently need surgery Ended
  2022-501353-37-00 Phase III 19 countries Astrazeneca AB

Showing 1–19 of 19 trials